Analysts Set Neumora Therapeutics, Inc. (NASDAQ:NMRA) Target Price at $16.50
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year […]
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year […]
